StratX™ Lung Analysis Platform
5Pages

Lung Analysis Platform Treat with Confidence

StratX™ Lung Analysis Platform A cloud-based quantitative CT analysis service that supports endobronchial valve (EBV) patient selection and treatment targeting by providing clinically-validated information on emphysema destruction, fissure completeness and lobar volumes ^ Pulmonx EBV therapy is the most rigorously studied minimally-invasive treatment for severe emphysema and is proven to improve patients’ breathing function, exercise capacity and quality of life.1 90% Accuracy in identifying EBV responders and non-responders when combined with selective use of the Chartis Pulmonary...

% Fissure Completeness Fissure Completeness Clinically-validated algorithm SIDE RIGHT LUNG The StratX analysis quantifies the completeness of each fissure using an Upload Date 27 July 2016 algorithm that has been validatedDate 27 July 2016 study of over 200 EBV in a retrospective Report Scan ID 0026671 2 16 February largest such analysis performed to date. Fissure completeness Scan Comments CT Scan Date patients, the2011 is a proven predictor for volume reduction resulting from EBV therapy.3 Patient ID 35-127-AJJ RIGHT LUNG for fissure completeness BACK % Fissure Completeness SIDE RIGHT...

Capture a high resolution chest CT scan according to the StratX CT parameters. Use web browser to upload CT scan to the secure, cloud-based StratX platform. • Automatically anonymized data with no patient health information transfer • Secure 256 bit SSL socket level encryption Workflow with rapid turnaround time Analyze Data + Generate Report StratX Lung Report TM Upload Date 27 July 2016 Report Date 27 July 2016 Scan ID 0026671 CT Scan Date 16 February 2011 Scan Comments SUMMARY KE Y ≥70% Voxel Density Less Than -910 HU 60-70% Voxel Density Less Than -910 HU 50-60% Voxel Density Less Than...

Lung Analysis Platform enables you to: 1 Potentially offer EBV therapy to more patients Non-invasively screen treatment candidates Chose between multiple potential treatment targets if applicable Enhance case planning and optimize procedure time Compare quantitative analyses across patients Educate referrers about the optimal candidate for EBV therapy Educate patients using user-friendly reports Support compliance and good documentation practices Contact us for more information: info@pulmonxstratx.com Pulmonx International Sàrl Rue de la Treille 4 2000 Neuchâtel, Switzerland Tel: +41 32 475...